Growth Metrics

Tandem Diabetes Care (TNDM) Gross Profit Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 6.52%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.76%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 4.41%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 12.59%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 15.74%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 6.30%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 27.39%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -1.74%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 8.72%
10 Tandem Diabetes Care 1.31 Bn 739.55 Mn 136.79 Mn 15.52%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 15.52%
Dec 31, 2025 6.35%
Sep 30, 2025 7.73%
Jun 30, 2025 11.58%
Mar 31, 2025 25.07%
Dec 31, 2024 68.77%
Sep 30, 2024 38.88%
Jun 30, 2024 10.87%
Mar 31, 2024 14.19%
Dec 31, 2023 -19.24%
Sep 30, 2023 -14.05%
Jun 30, 2023 -0.21%
Mar 31, 2023 -8.99%
Dec 31, 2022 1.58%
Sep 30, 2022 7.94%
Jun 30, 2022 10.27%
Mar 31, 2022 24.30%
Dec 31, 2021 25.59%
Sep 30, 2021 48.13%
Jun 30, 2021 69.98%
Mar 31, 2021 45.81%
Dec 31, 2020 50.25%
Sep 30, 2020 28.87%
Jun 30, 2020 8.99%
Mar 31, 2020 50.69%
Dec 31, 2019 45.11%
Sep 30, 2019 132.53%
Jun 30, 2019 230.77%
Mar 31, 2019 192.47%
Dec 31, 2018 137.78%
Sep 30, 2018 83.58%
Jun 30, 2018 88.56%
Mar 31, 2018 68.87%
Dec 31, 2017 73.55%
Sep 30, 2017 852.89%
Jun 30, 2017 -2.14%
Mar 31, 2017 -2.51%
Dec 31, 2016 -25.21%
Sep 30, 2016 -128.61%
Jun 30, 2016 70.30%
Mar 31, 2016 146.69%
Dec 31, 2015 105.87%
Sep 30, 2015 25.41%
Jun 30, 2015 39.24%
Mar 31, 2015 223.88%
Dec 31, 2014 450.25%
Sep 30, 2014 73.55%
Jun 30, 2014 749.26%
Mar 31, 2014 -57.50%